EASL recommendations on treatment of hepatitis C: Final update of the series().
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guidelines Panel: Chair:; EASL Governing Board representative:; Panel members:.
Chronic hepatitis C: Diagnosis and treatment made easy.
Abu-Freha N, Mathew Jacob B, Elhoashla A, Afawi Z, Abu-Hammad T, Elsana F, Paz S, Etzion O.
Eur J Gen Pract. 2022 Dec;28(1):102-108. doi: 10.1080/13814788.2022.2056161.
PMID:35579223
Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis.
Ali RO, Quinn GM, Umarova R, Haddad JA, Zhang GY, Townsend EC, Scheuing L, Hill KL, Gewirtz M, Rampertaap S, Rosenzweig SD, Remaley AT, Han JM, Periwal V, Cai H, Walter PJ, Koh C, Levy EB, Kleiner DE, Etzion O, Heller T.
Nat Microbiol. 2023 Jan;8(1):12-27. doi: 10.1038/s41564-022-01273-y. Epub 2022 Dec 15.
PMID:36522461
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis.
Akhtar E, Manne V, Saab S.
Liver Int. 2015 Jan;35(1):30-6. doi: 10.1111/liv.12576. Epub 2014 May 22.
PMID:24766091
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.